ECORIN-75 75MG ORAL SOLID ORDINARY TABLETS Uganda - angleščina - National Drug Authority

ecorin-75 75mg oral solid ordinary tablets

usv private limited - aspirin - oral solid ordinary tablets - 75mg

GLYCOMET 850 850MG ORAL SOLID ORDINARY TABLETS Uganda - angleščina - National Drug Authority

glycomet 850 850mg oral solid ordinary tablets

usv private limited - metformin - oral solid ordinary tablets - 850mg

GROVIT SYRUP MULTI-INGREDIENT ORAL LIQUID ORDINARY SYRUPS Uganda - angleščina - National Drug Authority

grovit syrup multi-ingredient oral liquid ordinary syrups

usv private limited - multi-ingredient - oral liquid ordinary syrups - multi-ingredient

GLYCOMET 500 500MG ORAL SOLID ORDINARY TABLETS Uganda - angleščina - National Drug Authority

glycomet 500 500mg oral solid ordinary tablets

usv private limited - metformin - oral solid ordinary tablets - 500mg

GROVIT CHEWABLE TABLETS MULTI-INGREDIENT ORAL SOLID ORDINARY CHEWABLE TABLETS Uganda - angleščina - National Drug Authority

grovit chewable tablets multi-ingredient oral solid ordinary chewable tablets

usv private limited - multi-ingredient - oral solid ordinary chewable tablets - multi-ingredient

DUOTROL 5MG + 500MG ORAL SOLID ORDINARY TABLETS Uganda - angleščina - National Drug Authority

duotrol 5mg + 500mg oral solid ordinary tablets

usv private limited - glyburide + metformin hydrochloride - oral solid ordinary tablets - 5mg + 500mg

DESIPRAMINE HYDROCHLORIDE tablet Združene države Amerike - angleščina - NLM (National Library of Medicine)

desipramine hydrochloride tablet

chartwell rx, llc - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride tablets is indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with desipramine hydrochloride or within 14 days of stopping treatment with desipramine hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of desipramine hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration). starting desipramine hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration). desipramine hydrochloride is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.

APO-Imiquimod Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

apo-imiquimod

apotex nz ltd - imiquimod 12.5mg - topical cream - 5% w/w - active: imiquimod 12.5mg excipient: benzyl alcohol cetyl alcohol glycerol isostearic acid methyl hydroxybenzoate polysorbate 60 propyl hydroxybenzoate purified water sorbitan stearate stearyl alcohol white soft paraffin xanthan gum - indicated for the topical treatment of actinic keratosis on the face and scalp in immunocompetent adults.

Metformin Viatris Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

metformin viatris

viatris limited - metformin hydrochloride 1000mg;  ;   - film coated tablet - 1000 mg - active: metformin hydrochloride 1000mg     excipient: magnesium stearate opadry clear 20c59060 povidone - metformin is indicated for the treatment of type 2 diabetes mellitus in adults, not satisfactorily controlled by diet, where the risk of lactic acidosis is minimised by excluding predisposing factors, especially impaired renal, hepatic or cardiovascular function. metformin may be used as initial therapy or in sulphonylurea failure, either alone or in combination with a sulphonylurea or as adjuvant therapy in insulin-dependent diabetes.